J Physiol Editor in Chief
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 532, Number 1, 127-142, April 1, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, P. A.
Right arrow Articles by Humphrey, P. P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, P. A.
Right arrow Articles by Humphrey, P. P. A.
Journal of Physiology (2001), 532.1, pp. 127-142
© Copyright 2001 The Physiological Society

Somatostatin activates two types of inwardly rectifying K+ channels in MIN-6 cells


Paul A. Smith, Lynda A. Sellers and Patrick P. A. Humphrey


Glaxo Institute of Applied Pharmacology, Department of Pharmacology, Tennis Court Road, Cambridge CB2 1QJ, UK

  1. Western blotting revealed the presence of five somatostatin receptor types, sst1, sst2, sst3, sst4 and sst5, in the mouse pancreatic beta-cell line MIN-6.

  2. In MIN-6 cells, glucose-induced electrical activity was potently (pEC50 = 12.7) and irreversibly reduced by somatostatin (SRIF-14); this was associated with hyperpolarization of the membrane potential (pEC50 = 11.2) and a decrease in the input resistance (pEC50 = 12.7).

  3. The effects of SRIF-14 were mimicked by 100 nM L-362,855 (a partial agonist at sst5 receptors), but not BIM-23027 or NNC-26,9100 (selective agonists at sst2 and sst4 receptors, respectively). CH-275 at 100 nM (a selective agonist at sst1 receptors) partially inhibited electrical activity but without membrane potential hyperpolarization.

  4. One hundred nanomolar SRIF-28 activated an inwardly rectifying K+ current (ISRIF) ISRIF was activated neither by 1 muM BIM-23056 nor CYN-154806 (antagonists at sst5 and sst2 receptors, respectively). The activation of ISRIF by 100 nM SRIF-28 was, however, inhibited 93 % by BIM-23056; CYN-154806 had no effect.

  5. Both 100 nM glibenclamide and 200 muM tolbutamide, blockers of the beta-cell ATP-sensitive K+ channel (K-ATP), reduced ISRIF by ~44 %, whereas 1 mM Ba2+ abolished ISRIF.

  6. In cell-attached patches, 100 nM SRIF-14 activated two types of single-channel currents whose properties were consistent with those of K-ATP and GIRK channels.

  7. In conclusion, somatostatin can inhibit glucose-induced electrical activity in MIN-6 cells by the combined activation of K-ATP and GIRK channels. Studies with selective agonists and antagonists are consistent with this effect being mediated by the sst5 receptor.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Zhao, Q. Fang, S. G. Straub, and G. W. G. Sharp
Both Gi and Go Heterotrimeric G Proteins Are Required to Exert the Full Effect of Norepinephrine on the {beta}-Cell KATP Channel
J. Biol. Chem., February 29, 2008; 283(9): 5306 - 5316.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Ma, J. Berg, and G. Yellen
Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening KATP Channels
J. Neurosci., April 4, 2007; 27(14): 3618 - 3625.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Daunt, O. Dale, and P. A. Smith
Somatostatin Inhibits Oxidative Respiration in Pancreatic {beta}-Cells
Endocrinology, March 1, 2006; 147(3): 1527 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Sieg, J. Su, A. Munoz, M. Buchenau, M. Nakazaki, L. Aguilar-Bryan, J. Bryan, and S. Ullrich
Epinephrine-induced hyperpolarization of islet cells without KATP channels
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E463 - E471.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev, January 1, 2004; 84(1): 239 - 275.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Ibrahim, M. A. Bosch, J. L. Smart, J. Qiu, M. Rubinstein, O. K. Ronnekleiv, M. J. Low, and M. J. Kelly
Hypothalamic Proopiomelanocortin Neurons Are Glucose Responsive and Express KATP Channels
Endocrinology, April 1, 2003; 144(4): 1331 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. E. Doyle and J. M. Egan
Pharmacological Agents That Directly Modulate Insulin Secretion
Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q.-Q. Sun, J. R. Huguenard, and D. A. Prince
Somatostatin Inhibits Thalamic Network Oscillations In Vitro: Actions on the GABAergic Neurons of the Reticular Nucleus
J. Neurosci., July 1, 2002; 22(13): 5374 - 5386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 The Physiological Society.